zepbound is semaglutide or tirzepatide (tirzepatide) superior to Wegovy (semaglutide), says Lilly-funded clinical trial Lilly's Zepbound tops Wegovy for

Misra emphasizes that people usually tolerate the injection similarly, whether they take it in the morning or evening

People taking semaglutide for weight loss may experience: Stomach issues like nausea, bloat, or extreme fullness Dizziness, headache, or fatigue Gastrointestinal issues, such as diarrhea, constipation and gassiness GI issues are the most common complaint among people just starting semaglutide

Countries like China, India, and Japan are at the forefront of boosting market growth in Asia-Pacific

Iranian Journal of Basic Medical Sciences, 25 (10), 1166-1176

While retatrutide appears to demonstrate a higher absolute weight loss potential in clinical trial settings, a nuanced comparative analysis is essential